BioMS to continue multiple sclerosis trial PharmaBiz Tue, 10 Apr 2007 2:49 AM PDT BioMS Medical Corp., a leading developer in the treatment of multiple sclerosis (MS), has announced that the independent Data Safety Monitoring Board (DSMB) for the company's pivotal phase II/III Maestro-01 trial of MBP8298 in patients with secondary progressive MS has completed a planned interim safety analysis and recommended that the trial continue as per the protocol.

Modified bone marrow cells can help recovery in an animal model of multiple sclerosis EurekAlert! Mon, 09 Apr 2007 5:08 PM PDT A new study published in PLoS Medicine has shown that modified bone marrow cells can help recovery in an animal model of multiple sclerosis (MS). Harald Neumann and colleagues from the University of Bonn modified myeloid precursor cells to express a protein (triggering receptor expressed on myeloid cells-2 (TREM2), which is normally made by microglia - a cell from the nervous system - and ...

Pick up a book, fight a disease Mayerthorpe Freelancer Mon, 09 Apr 2007 2:21 PM PDT You may see more Elmer Elson student?s noses in a good book this April. Elmer Elson has chosen Multiple Sclerosis as their fund raiser this year and the students are hitting the books to try and find a cure.

New BIO Study Confirms Innovative Therapies Will Have Minimal Impact on Healthcare Costs
RedNova Tue, 10 Apr 2007 10:23 AM PDT
The widening use of new, innovative biopharmace